"Health News - Medicine, Diet and Fitness"

CHICAGO, Sept. 19 — When it comes to curing TB quickly, it may be better to be a mouse than a man. Action Points
Explain to interested patients that researchers have been trying to tweak the gold standard regimen for TB therapy in the hope of speeding up the cure, which now takes about six months.

Note that research presented here shows that some regimen changes that worked in mice don’t appear to work in humans, although other alterations have a benefit.

This study was published as an abstract and presented orally at a conference. These data and conclusions should be considered to be preliminary until they have been published in a peer-reviewed journal.

(more…)

CHICAGO, Sept. 18 — The investigative integrase inhibitor raltegravir (Isentress) suppresses the viral load to undetectable levels in at least half of HIV patients with virus resistant to three drug classes, researchers said here.

All doses of raltegravir were superior to an optimized background of available antiretrovirals, Jose Gatell, M.D., of the University of Barcelona, told attendees at the Interscience Conference on Antimicrobial Agents and Chemotherapy. Action Points
Explain to interested patients that optimized background medication remains important for treatment of HIV-infected patients.
(more…)